1. Home
  2. SHEN vs PRTA Comparison

SHEN vs PRTA Comparison

Compare SHEN & PRTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Shenandoah Telecommunications Co

SHEN

Shenandoah Telecommunications Co

HOLD

Current Price

$11.83

Market Cap

634.6M

ML Signal

HOLD

Logo Prothena Corporation plc

PRTA

Prothena Corporation plc

HOLD

Current Price

$8.76

Market Cap

538.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SHEN
PRTA
Founded
1902
2012
Country
United States
Ireland
Employees
N/A
N/A
Industry
Telecommunications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
634.6M
538.3M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
SHEN
PRTA
Price
$11.83
$8.76
Analyst Decision
Strong Buy
Buy
Analyst Count
1
9
Target Price
$26.00
$18.86
AVG Volume (30 Days)
274.0K
496.8K
Earning Date
02-19-2026
02-19-2026
Dividend Yield
0.85%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$351,674,000.00
$11,786,000.00
Revenue This Year
$10.77
N/A
Revenue Next Year
$4.96
$1,183.79
P/E Ratio
N/A
N/A
Revenue Growth
13.24
N/A
52 Week Low
$9.67
$4.32
52 Week High
$15.84
$16.67

Technical Indicators

Market Signals
Indicator
SHEN
PRTA
Relative Strength Index (RSI) 56.11 39.86
Support Level $11.69 $8.39
Resistance Level $12.24 $9.05
Average True Range (ATR) 0.38 0.50
MACD 0.05 -0.07
Stochastic Oscillator 68.75 17.76

Price Performance

Historical Comparison
SHEN
PRTA

About SHEN Shenandoah Telecommunications Co

Shenandoah Telecommunications Company, with its subsidiaries, provides various broadband communication products and services via its wireless, cable, fiber optic, and fixed wireless networks to customers in the Mid-Atlantic United States. The company operates through one business unit: Broadband. The broadband segment provides broadband Internet, video, and voice services to residential and commercial customers. The broadband segment generates the vast majority of the company's revenue, with the bulk of sales flowing from residential and small, and medium businesses within the broadband unit.

About PRTA Prothena Corporation plc

Prothena Corp PLC is a clinical biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating neurodegenerative and rare and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including ATTR amyloidosis [Coramitug (PRX004)], Alzheimer's disease (PRX123), Neurodegeneration (PRXPRX019), and Others.

Share on Social Networks: